DIC India Q2 FY26: Profit Surges 196% Despite Revenue Stagnation

Nov 14 2025 09:26 AM IST
share
Share Via
DIC India Ltd., a micro-cap chemical products manufacturer with a market capitalisation of ₹474.55 crores, reported a remarkable 196.46% year-on-year surge in net profit to ₹5.87 crores for Q2 FY26, up from ₹1.98 crores in Q2 FY25. However, this impressive bottom-line growth masked a tepid revenue performance, with net sales rising just 1.03% YoY to ₹222.23 crores. The stock, trading at ₹517.00 as of November 14, 2025, has declined 28.19% over the past year, significantly underperforming both the Sensex and its sector peers.





Net Profit (Q2 FY26)

₹5.87 Cr

▲ 196.46% YoY



Revenue Growth (Q2 FY26)

1.03%

YoY Growth



Operating Margin (Q2 FY26)

5.28%

Highest in 7 Quarters



PAT Margin (Q2 FY26)

2.64%

▲ 174 bps YoY




The quarter's standout feature was the dramatic improvement in profitability metrics despite flat revenue growth. Operating profit margin excluding other income climbed to 5.28%, the highest in seven quarters, whilst PAT margin expanded to 2.64% from 0.90% in Q2 FY25. On a sequential basis, net profit grew 34.63% from ₹4.36 crores in Q1 FY26, whilst revenue declined marginally by 1.58% quarter-on-quarter.



DIC India, a subsidiary of DIC Asia Pacific Pte Limited, Singapore, operates in the chemical products sector with promoter holding stable at 71.75%. The company's recent results paint a picture of operational efficiency gains offsetting revenue headwinds, though the sustainability of this margin expansion remains questionable given the sluggish top-line performance.









































































Quarter Net Sales (₹ Cr) QoQ Change Net Profit (₹ Cr) QoQ Change PAT Margin
Sep'25 222.23 -1.58% 5.87 +34.63% 2.64%
Jun'25 225.80 +7.90% 4.36 +68.34% 1.93%
Mar'25 209.26 -4.21% 2.59 -63.78% 1.24%
Dec'24 218.46 -0.68% 7.15 +261.11% 3.27%
Sep'24 219.96 -9.02% 1.98 -68.12% 0.90%
Jun'24 241.76 +22.51% 6.21 +47.86% 2.57%
Mar'24 197.34 4.20 2.13%



Financial Performance: Margin Expansion Drives Profitability



In Q2 FY26, DIC India's net sales stood at ₹222.23 crores, representing modest growth of 1.03% year-on-year but a 1.58% sequential decline from Q1 FY26's ₹225.80 crores. The revenue trajectory over the past seven quarters reveals significant volatility, with the company struggling to achieve consistent top-line momentum. The peak quarterly revenue of ₹241.76 crores in Jun'24 has not been replicated since, indicating potential demand-side challenges or competitive pressures in the chemical products segment.



The real story, however, lies in margin improvement. Operating profit before depreciation, interest, and tax (excluding other income) surged to ₹11.74 crores in Q2 FY26, marking the highest level in the past seven quarters. The corresponding operating margin of 5.28% represents a substantial 197 basis points expansion from 3.31% in Q2 FY25. This improvement stems from better cost management, with total expenditure growing slower than revenue.





Revenue (Q2 FY26)

₹222.23 Cr

▲ 1.03% YoY | ▼ 1.58% QoQ



Net Profit (Q2 FY26)

₹5.87 Cr

▲ 196.46% YoY | ▲ 34.63% QoQ



Operating Margin (Q2 FY26)

5.28%

▲ 197 bps YoY



PAT Margin (Q2 FY26)

2.64%

▲ 174 bps YoY




Employee costs remained relatively stable at ₹18.81 crores in Q2 FY26, down marginally from ₹18.76 crores a year ago. Interest expenses were minimal at ₹0.33 crores, reflecting the company's debt-free balance sheet with a net debt-to-equity ratio of -0.09, indicating a net cash position. Depreciation charges stood at ₹4.67 crores, slightly lower than ₹4.76 crores in Q2 FY25.



The effective tax rate normalised to 25.98% in Q2 FY26, down from an unusually high 46.65% in Q2 FY25, which had significantly suppressed prior-year profits. This normalisation of the tax rate contributed meaningfully to the year-on-year profit surge. On a half-yearly basis (H1 FY26), net profit totalled ₹10.23 crores compared to ₹8.19 crores in H1 FY25, representing 24.91% growth.



Operational Challenges: Weak Returns and Growth Concerns



Beneath the surface-level profit growth lies a concerning operational reality. DIC India's return on equity (ROE) stands at a paltry 2.77% on average, with the latest figure at 3.72%—far below industry standards and peer performance. Return on capital employed (ROCE) is equally anaemic at 2.05% on average and 3.84% most recently. These metrics suggest the company is generating minimal returns on the capital invested, raising questions about the quality and sustainability of earnings.



The company's five-year sales growth compounds at just 5.22% annually, whilst operating profit (EBIT) has grown at 18.65% over the same period. Whilst the EBIT growth appears impressive, the low base effect and volatile quarterly performance diminish its significance. The sales-to-capital employed ratio of 1.93x indicates moderate asset efficiency but nothing exceptional.




Critical Concern: Deteriorating Capital Efficiency


ROE of 2.77% and ROCE of 2.05% place DIC India amongst the weakest performers in the chemical sector. These returns are barely above risk-free rates, indicating the company is destroying shareholder value rather than creating it. The debt-free balance sheet, whilst positive from a risk perspective, suggests management may be too conservative in deploying capital for growth.




The company's quality grade is rated as "Average" based on long-term financial performance. Whilst DIC India benefits from zero debt and no promoter pledging, the absence of institutional investor interest (0.00% institutional holdings) signals a lack of confidence from sophisticated market participants. The EBIT-to-interest coverage ratio of 4.70x, whilst adequate, is classified as "weak" relative to industry benchmarks.



Market Context: Severe Underperformance Amidst Sector Resilience



DIC India's stock performance tells a tale of investor disillusionment. Over the past year, the stock has plummeted 28.19%, whilst the Sensex gained 8.63%, resulting in a negative alpha of -36.82 percentage points. The underperformance extends across multiple timeframes: the stock is down 22.40% year-to-date versus Sensex's 7.85% gain, and has declined 20.36% over six months against the benchmark's 3.62% rise.



The chemical sector, represented by the "Other Chemical Products" category, delivered a 7.47% return over the past year, meaning DIC India underperformed its immediate peer group by 35.66 percentage points. This severe underperformance reflects market scepticism about the company's growth prospects and operational efficiency.

























































Period Stock Return Sensex Return Alpha
1 Week +1.97% +1.27% +0.70%
1 Month -1.96% +2.74% -4.70%
3 Months -13.45% +4.56% -18.01%
6 Months -20.36% +3.62% -23.98%
Year-to-Date -22.40% +7.85% -30.25%
1 Year -28.19% +8.63% -36.82%
3 Years +31.55% +36.75% -5.20%



Technical indicators paint a uniformly bearish picture. The stock currently trades in a bearish trend that commenced on November 6, 2025, at ₹499. All key moving averages—5-day (₹510.80), 20-day (₹517.23), 50-day (₹542.11), 100-day (₹582.42), and 200-day (₹621.61)—are above the current price of ₹517.00, indicating sustained selling pressure. The stock has fallen 36.95% from its 52-week high of ₹820.00, though it sits just 6.15% above its 52-week low of ₹487.05.



The risk-adjusted return profile is particularly concerning: DIC India's risk-adjusted return over one year stands at -0.50 with volatility of 56.40%, placing it firmly in the "HIGH RISK LOW RETURN" category. The stock's beta of 1.50 indicates it is 50% more volatile than the broader market, amplifying downside moves during market corrections.



Peer Comparison: Valuation Discount Reflects Fundamental Weakness



When benchmarked against peers in the chemical products sector, DIC India's structural challenges become evident. The company's ROE of 2.77% pales in comparison to sector peers such as Refex Industries (23.25%), Keltech Energies (14.31%), and Stallion India (10.75%). Only GOCL Corporation (7.06%) and Premium Explosives (6.18%) show similarly weak returns, though both outperform DIC India.


























































Company P/E Ratio P/BV Ratio ROE Dividend Yield
DIC India 30.69 1.14 2.77% 0.77%
Refex Industries 28.24 3.83 23.25% 0.13%
Premium Explosives 80.07 13.03 6.18% 0.08%
Stallion India 54.58 5.55 10.75%
GOCL Corporation 6.27 1.05 7.06% 3.00%
Keltech Energies 16.92 3.58 14.31% 0.03%



Despite its weak fundamentals, DIC India trades at a P/E ratio of 30.69x, which appears expensive given the anaemic ROE. The price-to-book ratio of 1.14x is amongst the lowest in the peer group, reflecting market recognition of the company's poor capital efficiency. The dividend yield of 0.77% offers little compensation for the risk, with a dividend payout ratio of just 18.79% suggesting management lacks confidence in deploying retained earnings productively.



The valuation discount relative to high-quality peers like Refex Industries (P/BV of 3.83x with 23.25% ROE) or Keltech Energies (P/BV of 3.58x with 14.31% ROE) is justified. DIC India's market capitalisation of ₹474.55 crores places it fifth amongst the peer group, limiting institutional interest and liquidity.




"When a company trades at 30x earnings but delivers barely 3% returns on equity, the market is either pricing in a dramatic turnaround or hasn't fully recognised the value trap."


Valuation Analysis: Expensive Despite Recent Decline



DIC India's valuation metrics present a paradox. The stock trades at a P/E ratio of 31x, above the five-year average and in line with sector median, despite delivering sub-par returns. The EV/EBITDA multiple of 13.37x and EV/EBIT of 30.12x appear reasonable on the surface but fail to account for the quality of earnings and low incremental returns on invested capital.



The company's proprietary valuation grade recently oscillated between "Fair" and "Expensive," currently settling on "Fair" as of October 13, 2025. However, this assessment appears generous given the fundamental challenges. The PEG ratio of 1.67x suggests the stock is trading at a premium to its growth rate, which itself is unimpressive at 5.22% for sales over five years.





P/E Ratio (TTM)

31x

vs Industry 42x



Price to Book

1.14x

Below Peer Average



Dividend Yield

0.77%

₹4 per share



Mojo Score

34/100

SELL Rating




The stock's 52-week range of ₹487.05 to ₹820.00 reveals significant volatility. At the current price of ₹517.00, the stock has corrected 36.95% from its peak, yet remains 6.15% above its recent low. Given the weak fundamentals and deteriorating technical picture, further downside risk exists, with support likely at the ₹487 level.



Shareholding: Stable Promoter Base, Zero Institutional Interest



DIC India's shareholding pattern has remained remarkably stable over the past five quarters. Promoter holding stands firm at 71.75%, unchanged since at least September 2024. The promoter entity, DIC Asia Pacific Pte Ltd., maintains a controlling stake with zero pledging, indicating financial stability at the parent level.

























































Quarter Promoter FII Mutual Funds Insurance Non-Institutional
Sep'25 71.75% 0.00% 0.00% 0.00% 28.25%
Jun'25 71.75% 0.00% 0.00% 0.00% 28.25%
Mar'25 71.75% 0.00% 0.00% 0.00% 28.25%
Dec'24 71.75% 0.00% 0.00% 0.00% 28.25%
Sep'24 71.75% 0.00% 0.00% 0.00% 28.24%



The concerning aspect is the complete absence of institutional investors. Foreign institutional investors (FIIs), mutual funds, insurance companies, and other domestic institutional investors (DIIs) collectively hold 0.00% of the company. This lack of institutional participation reflects the stock's poor liquidity, weak fundamentals, and limited growth visibility. The entire non-promoter shareholding of 28.25% comprises retail and non-institutional investors, who typically lack the resources for deep fundamental analysis.



The stability in shareholding, whilst indicating no promoter exit risk, also suggests stagnation. There has been no meaningful change in ownership structure that might signal improving confidence or strategic shifts. For a micro-cap stock seeking to attract growth capital, the absence of institutional interest is a significant red flag.



Investment Thesis: Limited Upside, Mounting Risks



DIC India's investment thesis rests on fragile foundations. The company's proprietary Mojo Score of 34/100 places it firmly in "SELL" territory, with the rating downgraded from "HOLD" on May 27, 2025. The score reflects a combination of weak fundamentals, bearish technicals, and expensive valuation relative to quality.





Valuation Grade

FAIR

Recently Volatile



Quality Grade

AVERAGE

Weak Returns



Financial Trend

POSITIVE

Q2 Improvement



Technical Trend

BEARISH

Since Nov 6




The quarterly financial trend turned positive in Q2 FY26, driven by margin expansion and profit growth. However, this single-quarter improvement must be viewed against the backdrop of multi-year underperformance and structural challenges. The bearish technical trend, which commenced on November 6, 2025, suggests the market remains sceptical of sustainability.



Key concerns limiting the investment case include poor long-term growth (5.22% sales CAGR over five years), weak capital efficiency (2.77% ROE), and complete absence of institutional investor confidence. The stock's high beta of 1.50 and severe underperformance versus both benchmark and sector peers further diminish its appeal.



Key Strengths & Risk Factors





✅ KEY STRENGTHS



  • Debt-Free Balance Sheet: Net debt-to-equity of -0.09 indicates net cash position, providing financial flexibility

  • Margin Improvement: Operating margin reached 5.28% in Q2 FY26, highest in seven quarters

  • Stable Promoter Holding: 71.75% promoter stake with zero pledging demonstrates commitment

  • Recent Profit Momentum: Net profit surged 196.46% YoY in Q2 FY26 to ₹5.87 crores

  • Cost Management: Employee costs and interest expenses remain well-controlled

  • Normalised Tax Rate: Tax rate at 25.98% versus abnormal 46.65% in prior year




⚠️ KEY CONCERNS



  • Anaemic ROE: Return on equity of 2.77% is amongst the weakest in the sector, barely above risk-free rates

  • Revenue Stagnation: Sales growth of just 1.03% YoY and 5.22% over five years signals demand weakness

  • Zero Institutional Interest: Complete absence of FII, MF, and insurance holdings reflects poor market confidence

  • Severe Stock Underperformance: Down 28.19% over one year versus Sensex gain of 8.63%

  • Bearish Technical Trend: Stock below all major moving averages with deteriorating momentum

  • High Volatility: Beta of 1.50 and volatility of 56.40% place it in high-risk category

  • Limited Liquidity: Micro-cap status with market cap of ₹474.55 crores restricts institutional participation





Outlook: What Lies Ahead





POSITIVE CATALYSTS



  • Sustained margin expansion beyond 5% levels

  • Revenue growth acceleration above 10% YoY

  • ROE improvement to double-digit levels

  • Entry of institutional investors signalling confidence

  • Technical trend reversal with stock reclaiming 200-day MA at ₹621




RED FLAGS TO MONITOR



  • Inability to sustain margin gains in coming quarters

  • Further revenue decline or stagnation

  • Break below 52-week low of ₹487

  • Continued absence of institutional buying interest

  • Deterioration in quarterly financial trend from current "Positive" status





The path forward for DIC India hinges on management's ability to translate recent margin gains into sustainable profit growth whilst addressing the structural revenue challenges. The chemical products sector faces headwinds from raw material volatility and competitive intensity, making consistent performance difficult for smaller players. Without a clear growth strategy or product differentiation, DIC India risks remaining a value trap—cheap for a reason.



For the stock to merit a re-rating, the company needs to demonstrate at least three consecutive quarters of revenue growth above 8-10% whilst maintaining margins at current levels or better. Additionally, attracting institutional investor interest would require ROE improvement to at least 8-10%, which would necessitate either significant profit growth or capital restructuring.




The Verdict: Margin Gains Cannot Mask Structural Weakness


SELL

Score: 34/100


For Fresh Investors: Avoid initiating positions. The combination of weak ROE (2.77%), stagnant revenue growth (1.03% YoY), and bearish technical trend presents an unfavourable risk-reward profile. The recent profit surge stems largely from margin expansion and tax normalisation rather than genuine business momentum. With the stock trading at 31x earnings despite delivering sub-par returns, better opportunities exist elsewhere in the chemical sector.


For Existing Holders: Consider exiting on any technical bounce towards the ₹540-550 zone (20-day and 50-day moving averages). The stock has declined 28.19% over the past year and shows no signs of trend reversal. Whilst the debt-free balance sheet provides downside protection, the opportunity cost of holding a stock with 2.77% ROE is substantial. The complete absence of institutional interest and persistent underperformance versus peers suggest limited near-term catalysts for re-rating.


Fair Value Estimate: ₹480-500 (7-8% downside from current levels), based on 25-27x P/E applied to normalised earnings of ₹18-20 per share, adjusted for weak ROE and limited growth visibility.





Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)





⚠️ Investment Disclaimer


This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.





{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Why is DIC India falling/rising?
Nov 21 2025 12:37 AM IST
share
Share Via
Is DIC India overvalued or undervalued?
Nov 17 2025 08:08 AM IST
share
Share Via
Is DIC India overvalued or undervalued?
Nov 16 2025 08:08 AM IST
share
Share Via
Is DIC India overvalued or undervalued?
Nov 15 2025 08:08 AM IST
share
Share Via
How has been the historical performance of DIC India?
Nov 13 2025 11:31 PM IST
share
Share Via